Eisner Mark 4
4 · Vir Biotechnology, Inc. · Filed Jul 17, 2025
Insider Transaction Report
Form 4
Eisner Mark
EVP and Chief Medical Officer
Transactions
- Sale
Common Stock
2025-07-15$5.47/sh−6,796$37,162→ 108,204 total - Sale
Common Stock
2025-07-17$5.47/sh−3,586$19,629→ 104,618 total
Footnotes (3)
- [F1]Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units.
- [F2]Represents shares sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 5, 2024.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.41 to $5.53, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.